XML 19 R8.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows – Operating activities:    
Net earnings, including noncontrolling interests $ 137,744 $ 73,053
Adjustments to reconcile net earnings to net cash provided (used) by operating activities:    
Depreciation 55,292 59,207
Amortization of intangible and other assets 7,782 10,051
Stock-based compensation 22,127 23,757
Foreign currency, asset write downs and other non-cash adjustments (11,827) (24,085)
Change in assets and liabilities:    
Accounts receivable, net 1,524 (78,376)
Inventories, net (114,596) (151,938)
Contract assets, net (10,239) (21,912)
Prepaid expenses and other, net (6,727) (14,881)
Accounts payable 1,910 29,307
Contract liabilities 15,879 27,237
Accrued liabilities and income taxes payable 21,429 (32,735)
Retirement obligations and other liabilities 38,838 24,123
Net deferred taxes (27,996) (32,293)
Net cash flows provided (used) by operating activities 131,140 (109,485)
Cash flows – Investing activities:    
Capital expenditures (47,544) (45,831)
Other (833) 184
Net cash flows provided (used) by investing activities (48,377) (45,647)
Cash flows – Financing activities:    
Payments on term loan (30,000) (24,239)
Proceeds under revolving credit facility 230,000 0
Payments under revolving credit facility (145,000) 0
Proceeds under other financing arrangements 242 1,135
Payments under other financing arrangements (2,098) (356)
Payments related to tax withholding for stock-based compensation (6,203) (4,578)
Payments of dividends (78,712) (78,406)
Other (320) (5,334)
Net cash flows provided (used) by financing activities (32,091) (111,778)
Effect of exchange rate changes on cash (5,185) (39,672)
Net change in cash and cash equivalents 45,487 (306,582)
Cash and cash equivalents at beginning of period 434,971 658,452
Cash and cash equivalents at end of period $ 480,458 $ 351,870